Resveratrol Derivatives Inhibit Pro-survival Akt Signaling Pathway in Lung Cancer

RD4 suppresses Akt pathways by binding at the allosteric site of Akt. These findings provide a rationale for the design and optimization of novel Akt targeting agents for non-small cell lung cancer treatment.

Authors

Institutions

Publication Details

Journal
Anticancer Research
Published
2025-06-27
DOI
https://doi.org/10.21873/anticanres.17667
Primary Topic
Sirtuins and Resveratrol in Medicine
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Resveratrol Derivatives Inhibit Pro-survival Akt Signaling Pathway in Lung Cancer

Pithi Chanvorachote, Zin Zin, Nicharat Sriratanasak, Satapat Racha et al.
Anticancer Research
Sirtuins and Resveratrol in Medicine
article

Resveratrol Derivatives Inhibit Pro-survival Akt Signaling Pathway in Lung Cancer

Pithi Chanvorachote, Zin Zin, Nicharat Sriratanasak, Satapat Racha, Bhurichaya Innets
article en

Abstract

RD4 suppresses Akt pathways by binding at the allosteric site of Akt. These findings provide a rationale for the design and optimization of novel Akt targeting agents for non-small cell lung cancer treatment.

Anticancer ResearchVol. 45(7)
Chulalongkorn University (TH)
Openalex Percentile: Top 82%
Sirtuins and Resveratrol in Medicine
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Resveratrol Derivatives Inhibit Pro-survival Akt Signaling Pathway in Lung Cancer — Pithi Chanvorachote, Zin Zin, et al. · Anticancer Research (2025) | TGRS Research Map | TGRS